Lipid Study Questions
1. Define primary versus secondary CAD prevention.
2. Define the different risk categories for CAD.
3. Define the NCEP LDL goals for the different risk category groups.
4. Define the LDL levels at which to consider drug therapy.
5. How long should initial TLC be attempted before reassessment after the initial visit?
6. What drug class is the most potent in terms of ability to lower LDL?
7. Describe the metabolic syndrome.
8. What are the two key interventions to controlling the risk factors associated with metabolic
9. What is a normal triglyceride level?
10. Define non-HDL cholesterol.
11. What is the goal for non-HDL cholesterol in persons with high triglyceride levels?
12. What is the initial goal of therapy for people with high (>200) triglycerides? What is the initial
goal for those with very high (>500) triglycerides?
13. Which drugs are primarily used for their ability to lower triglycerides?
14. At what LDL level do most diabetics need initiation of drug therapy to achieve their goal level?
15. For adult patients, what is the time interval at which fasting lipid profiles should be done?
16. List the major risk factors that modify LDL goals.
17. Which risk factor is negative?
18. When are Framingham scores used to estimate risk?
19. What does the Framingham score tell you?
20. Why don't we use Framingham scores in patients with 0-1 risk factor?
21. What things should be ruled out as causes of secondary dyslipidemia before beginning lipid
22. What is the goal of LDL lowering therapy in people considered at least med-high risk?
23. Why should niacin be used with caution in patients with diabetes?
24. What component of the lipid profile (i.e. LDL, HDL, triglycerides, VLDL) do we concentrate on
as our primary goal? When is this not true? Why?